Cargando…
CIRBP promotes ferroptosis by interacting with ELAVL1 and activating ferritinophagy during renal ischaemia‐reperfusion injury
Renal ischaemia‐reperfusion (IR) is a major cause of acute kidney injury (AKI). Cold‐inducible RNA‐binding protein (CIRBP) may contribute to AKI because its deficiency protects against renal IR injury in a mechanism believed to involve ferroptosis. We aimed to investigate whether ferroptosis is asso...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256344/ https://www.ncbi.nlm.nih.gov/pubmed/34114349 http://dx.doi.org/10.1111/jcmm.16567 |
_version_ | 1783718082913501184 |
---|---|
author | Sui, Mingxing Xu, Da Zhao, Wenyu Lu, Hanlan Chen, Rui Duan, Yazhe Li, Yanhua Zhu, Youhua Zhang, Lei Zeng, Li |
author_facet | Sui, Mingxing Xu, Da Zhao, Wenyu Lu, Hanlan Chen, Rui Duan, Yazhe Li, Yanhua Zhu, Youhua Zhang, Lei Zeng, Li |
author_sort | Sui, Mingxing |
collection | PubMed |
description | Renal ischaemia‐reperfusion (IR) is a major cause of acute kidney injury (AKI). Cold‐inducible RNA‐binding protein (CIRBP) may contribute to AKI because its deficiency protects against renal IR injury in a mechanism believed to involve ferroptosis. We aimed to investigate whether ferroptosis is associated with CIRBP‐mediated renal damage. The differential expression of CIRBP was examined in tubular epithelial (HK2) cells during hypoxia‐reoxygenation (HR) or in response to erastin, an inducer of ferroptosis. CIRBP expression was increased in response to HR or erastin in HK2 cells but the silencing of CIRBP inhibited HR and erastin‐induced ferroptosis together with ferritinophagy. We discovered an interaction between CIRBP and ELAVL1 using STRING software, which was verified through co‐immunoprecipitation and fluorescence colocalization assays. We found that ELAVL1 is a critical regulator in the activation of ferritinophagy and the promotion of ferroptosis. HR or erastin also induced the expression of ELAVL1. An autophagy inhibitor (hydroxychloroquine) or si‐ELAVL1 transfection reversed CIRBP‐enhanced ferritinophagy activation and ferroptosis in HK2 cells under HR. Injection of anti‐CIRBP antibody into a mouse model of IR inhibited ferroptosis and decreased renal IR injury in vivo. In summary, our results provide evidence that ferritinophagy‐mediated ferroptosis could be responsible for CIRBP‐enhanced renal IR injury. |
format | Online Article Text |
id | pubmed-8256344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82563442021-07-12 CIRBP promotes ferroptosis by interacting with ELAVL1 and activating ferritinophagy during renal ischaemia‐reperfusion injury Sui, Mingxing Xu, Da Zhao, Wenyu Lu, Hanlan Chen, Rui Duan, Yazhe Li, Yanhua Zhu, Youhua Zhang, Lei Zeng, Li J Cell Mol Med Original Articles Renal ischaemia‐reperfusion (IR) is a major cause of acute kidney injury (AKI). Cold‐inducible RNA‐binding protein (CIRBP) may contribute to AKI because its deficiency protects against renal IR injury in a mechanism believed to involve ferroptosis. We aimed to investigate whether ferroptosis is associated with CIRBP‐mediated renal damage. The differential expression of CIRBP was examined in tubular epithelial (HK2) cells during hypoxia‐reoxygenation (HR) or in response to erastin, an inducer of ferroptosis. CIRBP expression was increased in response to HR or erastin in HK2 cells but the silencing of CIRBP inhibited HR and erastin‐induced ferroptosis together with ferritinophagy. We discovered an interaction between CIRBP and ELAVL1 using STRING software, which was verified through co‐immunoprecipitation and fluorescence colocalization assays. We found that ELAVL1 is a critical regulator in the activation of ferritinophagy and the promotion of ferroptosis. HR or erastin also induced the expression of ELAVL1. An autophagy inhibitor (hydroxychloroquine) or si‐ELAVL1 transfection reversed CIRBP‐enhanced ferritinophagy activation and ferroptosis in HK2 cells under HR. Injection of anti‐CIRBP antibody into a mouse model of IR inhibited ferroptosis and decreased renal IR injury in vivo. In summary, our results provide evidence that ferritinophagy‐mediated ferroptosis could be responsible for CIRBP‐enhanced renal IR injury. John Wiley and Sons Inc. 2021-06-10 2021-07 /pmc/articles/PMC8256344/ /pubmed/34114349 http://dx.doi.org/10.1111/jcmm.16567 Text en © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Sui, Mingxing Xu, Da Zhao, Wenyu Lu, Hanlan Chen, Rui Duan, Yazhe Li, Yanhua Zhu, Youhua Zhang, Lei Zeng, Li CIRBP promotes ferroptosis by interacting with ELAVL1 and activating ferritinophagy during renal ischaemia‐reperfusion injury |
title | CIRBP promotes ferroptosis by interacting with ELAVL1 and activating ferritinophagy during renal ischaemia‐reperfusion injury |
title_full | CIRBP promotes ferroptosis by interacting with ELAVL1 and activating ferritinophagy during renal ischaemia‐reperfusion injury |
title_fullStr | CIRBP promotes ferroptosis by interacting with ELAVL1 and activating ferritinophagy during renal ischaemia‐reperfusion injury |
title_full_unstemmed | CIRBP promotes ferroptosis by interacting with ELAVL1 and activating ferritinophagy during renal ischaemia‐reperfusion injury |
title_short | CIRBP promotes ferroptosis by interacting with ELAVL1 and activating ferritinophagy during renal ischaemia‐reperfusion injury |
title_sort | cirbp promotes ferroptosis by interacting with elavl1 and activating ferritinophagy during renal ischaemia‐reperfusion injury |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256344/ https://www.ncbi.nlm.nih.gov/pubmed/34114349 http://dx.doi.org/10.1111/jcmm.16567 |
work_keys_str_mv | AT suimingxing cirbppromotesferroptosisbyinteractingwithelavl1andactivatingferritinophagyduringrenalischaemiareperfusioninjury AT xuda cirbppromotesferroptosisbyinteractingwithelavl1andactivatingferritinophagyduringrenalischaemiareperfusioninjury AT zhaowenyu cirbppromotesferroptosisbyinteractingwithelavl1andactivatingferritinophagyduringrenalischaemiareperfusioninjury AT luhanlan cirbppromotesferroptosisbyinteractingwithelavl1andactivatingferritinophagyduringrenalischaemiareperfusioninjury AT chenrui cirbppromotesferroptosisbyinteractingwithelavl1andactivatingferritinophagyduringrenalischaemiareperfusioninjury AT duanyazhe cirbppromotesferroptosisbyinteractingwithelavl1andactivatingferritinophagyduringrenalischaemiareperfusioninjury AT liyanhua cirbppromotesferroptosisbyinteractingwithelavl1andactivatingferritinophagyduringrenalischaemiareperfusioninjury AT zhuyouhua cirbppromotesferroptosisbyinteractingwithelavl1andactivatingferritinophagyduringrenalischaemiareperfusioninjury AT zhanglei cirbppromotesferroptosisbyinteractingwithelavl1andactivatingferritinophagyduringrenalischaemiareperfusioninjury AT zengli cirbppromotesferroptosisbyinteractingwithelavl1andactivatingferritinophagyduringrenalischaemiareperfusioninjury |